鄭煤機(601717.SH):擬推4230萬股的2021年限制性股票激勵計劃
格隆匯 4 月 18日丨鄭煤機(601717.SH)發佈2021年限制性股票激勵計劃(草案),擬授予的限制性股票數量為4230萬股,佔草案公吿時公司股本總額的2.442%。此次授予為一次性授予,無預留權益。
該計劃擬授予的限制性股票的來源為公司向激勵對象定向發行的人民幣A股普通股,限制性股票的授予價格為5.88元/股。
該計劃的激勵對象總人數為186人,包括在公司(含控股子公司)任職的董事、高級管理人員、核心管理人員和核心骨幹等(不包括獨立董事、監事及單獨或合計持有公司5%以上股份的股東或實際控制人及其配偶、父母、子女)。
該計劃授予的限制性股票各年度績效考核目標如下表所示:

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.